Uploaded June 2026 | Updated September 2026, 2 weeks ago
In this Expert Talk, Alon Ben Noon and Prof. Jeffrey Rosenfeld explore PrimeC – Connecting the Dots: Biomarkers, Survival, and the Future of ALS Research.
This session highlights the latest developments surrounding PrimeC, an innovative therapeutic approach being investigated for ALS, and examines the critical role biomarkers play in understanding disease progression and evaluating treatment effectiveness.
Alon Ben Noon and Prof. Rosenfeld discuss how emerging biomarker research may help connect important insights around survival, disease monitoring, and future therapeutic development. They also explore the broader ALS research landscape, the importance of clinical innovation, and the potential impact of new approaches for people living with ALS.
Throughout the discussion, the speakers share perspectives on advancing ALS care through research, improving clinical trial outcomes, and building a more data-driven future for ALS therapeutics.
In this talk, we cover:
• Introduction to PrimeC and its development
• The role of biomarkers in ALS research
• Understanding survival endpoints and disease progression
• How biomarkers can support future clinical trials
• The evolving ALS therapeutic landscape
• The future of personalized and targeted ALS treatments
• The importance of ongoing clinical research and patient participation
📲 Download the EverythingALS App
• Google Play: bit.ly/4nXqIYy
• App Store: bit.ly/42tPBmh
Follow EverythingALS:
► Website: everythingals.org
► X: https://x.com/everything_als
► LinkedIn: linkedin.com/company/everythingals
► Facebook: facebook.com/everythingals
► Subscribe for more Expert Talks: youtube.com/@EverythingALS
#ExpertTalk #EverythingALS #ALSResearch #ALSCommunity #PrimeC #Biomarkers #ClinicalTrials #ALSTreatment #ALSInnovation #Neurology #SurvivalResearch #JeffreyRosenfeld #AlonBenNoon #ClinicalResearch
In this Expert Talk, Alon Ben Noon and Prof. Jeffrey Rosenfeld explore PrimeC – Connecting the Dots: Biomarkers, Survival, and the Future of ALS Research.
This session highlights the latest developments surrounding PrimeC, an innovative therapeutic approach being investigated for ALS, and examines the critical role biomarkers play in understanding disease progression and evaluating treatment effectiveness.
Alon Ben Noon and Prof. Rosenfeld discuss how emerging biomarker research may help connect important insights around survival, disease monitoring, and future therapeutic development. They also explore the broader ALS research landscape, the importance of clinical innovation, and the potential impact of new approaches for people living with ALS.
Throughout the discussion, the speakers share perspectives on advancing ALS care through research, improving clinical trial outcomes, and building a more data-driven future for ALS therapeutics.
In this talk, we cover:
• Introduction to PrimeC and its development
• The role of biomarkers in ALS research
• Understanding survival endpoints and disease progression
• How biomarkers can support future clinical trials
• The evolving ALS therapeutic landscape
• The future of personalized and targeted ALS treatments
• The importance of ongoing clinical research and patient participation
📲 Download the EverythingALS App
• Google Play: bit.ly/4nXqIYy
• App Store: bit.ly/42tPBmh
Follow EverythingALS:
► Website: everythingals.org
► X: https://x.com/everything_als
► LinkedIn: linkedin.com/company/everythingals
► Facebook: facebook.com/everythingals
► Subscribe for more Expert Talks: youtube.com/@EverythingALS
#ExpertTalk #EverythingALS #ALSResearch #ALSCommunity #PrimeC #Biomarkers #ClinicalTrials #ALSTreatment #ALSInnovation #Neurology #SurvivalResearch #JeffreyRosenfeld #AlonBenNoon #ClinicalResearch
